Similar Articles
1231 Safety of hepatectomy for elderly patients with hepatocellular carcinoma
1232 Downregulation of signal transducer and activator of transcription 3 by sorafenib: A novel mechanism for hepatocellular carcinoma therapy
1233 Risk factor analysis of perioperative mortality after ruptured bleeding in hepatocellular carcinoma
1234 Laser ablation for small hepatocellular carcinoma: State of the art and future perspectives
1235 Targeting the insulin-like growth factor pathway in hepatocellular carcinoma
1236 Recent advances in the surgical treatment of hepatocellular carcinoma
1237 Complete response to sorafenib in a patient with recurrent hepatocellular carcinoma
1238 Apoptosis block as a barrier to effective therapy in non small cell lung cancer
1239 Interventional treatment for unresectable hepatocellular carcinoma
1240 Revisiting the role of pathological analysis in transarterial chemoembolization-treated hepatocellular carcinoma after transplantation
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA